Quarterly ResultAug 7, 2026, 04:20 PM
Omada Health Q2 Revenue +43.1% to $87.8M; Net Income $5.3M
AI Summary
Omada Health reported strong financial results for the second quarter and first half of 2026, marking a significant turnaround from the previous year. The company achieved a net income of $5.3 million in Q2 2026, reversing a net loss of $5.3 million in Q2 2025, driven by a 43.1% increase in total revenue to $87.8 million. For the six months ended June 30, 2026, Omada Health also posted a net income of $2.3 million, compared to a net loss of $14.8 million in the prior year period, with total revenue reaching $165.9 million.
Key Highlights
- Total revenue for Q2 2026 increased by 43.1% to $87.8 million from $61.4 million in Q2 2025.
- Net income for Q2 2026 was $5.3 million, a significant improvement from a net loss of $5.3 million in Q2 2025.
- Basic earnings per share (EPS) for Q2 2026 was $0.09, up from a loss of $0.24 in Q2 2025.
- Total revenue for the six months ended June 30, 2026, rose to $165.9 million from $116.3 million in the prior year period.
- Net income for the six months ended June 30, 2026, was $2.3 million, compared to a net loss of $14.8 million in the same period last year.
- Cash and cash equivalents stood at $221.7 million as of June 30, 2026, slightly down from $222.0 million at December 31, 2025.
- Total assets increased to $328.2 million as of June 30, 2026, from $305.4 million at December 31, 2025.
- Stockholders' equity grew to $252.7 million as of June 30, 2026, from $229.7 million at December 31, 2025.
Price Impact
More from OMDA